Date: prev next · Thread: first prev next last
2011 Archives by date, by thread · List index


Hello,

we're in the progress of migrating one of our servers to a new machine, and would like to replace the virtualization solution used by LXC.

Currently, we have vm1-vm4.documentfoundation.org with IP addresses of 188.40.32.161, 188.40.32.162, 188.40.32.163 and 188.40.32.185

Is there anything critical that is in productive use on one of these systems at the moment, or can we temporarily suspend the VMs for the migration?

- I recall that Litmus might still be inside such a VM. (@Sophie, Christian)

- The Silverstripe test instance is as well, but I guess it is not ultra-critical? (@Christian)

- How about the gerrit test instance? Is it in production use? (@Björn)

Anything else? I checked the DNS entries and found nothing else.

Thanks,
Florian

--
Florian Effenberger <floeff@documentfoundation.org>
Steering Committee and Founding Member of The Document Foundation
Tel: +49 8341 99660880 | Mobile: +49 151 14424108
Skype: floeff | Twitter/Identi.ca: @floeff

--
Unsubscribe instructions: E-mail to website+help@global.libreoffice.org
Problems? http://www.libreoffice.org/get-help/mailing-lists/how-to-unsubscribe/
Posting guidelines + more: http://wiki.documentfoundation.org/Netiquette
List archive: http://listarchives.libreoffice.org/global/website/
All messages sent to this list will be publicly archived and cannot be deleted

Context


Privacy Policy | Impressum (Legal Info) | Copyright information: Unless otherwise specified, all text and images on this website are licensed under the Creative Commons Attribution-Share Alike 3.0 License. This does not include the source code of LibreOffice, which is licensed under the Mozilla Public License (MPLv2). "LibreOffice" and "The Document Foundation" are registered trademarks of their corresponding registered owners or are in actual use as trademarks in one or more countries. Their respective logos and icons are also subject to international copyright laws. Use thereof is explained in our trademark policy.